Drug Shortage Report for LIDOCAINE HYDROCHLORIDE INJECTION USP

Last updated on 2025-03-02 History
Report ID 251173
Drug Identification Number 02422018
Brand name LIDOCAINE HYDROCHLORIDE INJECTION USP
Common or Proper name LIDOCAINE HYDROCHLORIDE INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LIDOCAINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration BLOCK/INFILTRATION BLOCK/INFILTRATION
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 50mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-03-01
Actual start date
Estimated end date 2025-05-31
Actual end date
Shortage status Actual shortage
Updated date 2025-03-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2025-03-02 English Compare
v2 2025-02-24 French Compare
v1 2025-02-24 English Compare

Showing 1 to 3 of 3